TD Capital Management’s Amgen AMGN Stock Holding History

TD Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.4K	Buy	52 +13	+33%	+$4.63K	﹤0.01%	379
2025 Q4	$12.7K	Sell	39 -26	-40%	-$8.25K	﹤0.01%	421
2025 Q3	$18.4K	Hold	65	–	–	﹤0.01%	336
2025 Q2	$18.1K	Buy	65 +39	+150%	+$11K	﹤0.01%	334
2025 Q1	$8.16K	Buy	+26	New	+$7.68K	﹤0.01%	330
2024 Q2	–	Sell	-25	Closed	-$7.11K	–	441
2024 Q1	$7.11K	Buy	+25	New	+$7.32K	﹤0.01%	308
2023 Q3	–	Sell	-4	Closed	-$955	–	412
2023 Q2	$955	Sell	4 -28	-88%	-$6.5K	﹤0.01%	388
2023 Q1	$7.85K	Hold	32	–	–	﹤0.01%	284
2022 Q4	$8.51K	Buy	32 +28	+700%	+$7.51K	﹤0.01%	260
2022 Q3	$1K	Buy	+4	New	+$970	﹤0.01%	332
2022 Q1	–	Sell	-4	Closed	-$1K	–	111
2021 Q4	$1K	Hold	4	–	–	﹤0.01%	358
2021 Q3	$1K	Hold	4	–	–	﹤0.01%	345
2021 Q2	$1K	Hold	4	–	–	﹤0.01%	330
2021 Q1	$1K	Buy	+4	New	+$954	﹤0.01%	301

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TD Capital Management's AMGN Position: Q1 2026 in Review

TD Capital Management increased its Amgen (AMGN) stake by 33% in Q1 2026, buying an estimated $4.63K and bringing the position to 52 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

TD Capital Management first reported a position in AMGN in Q1 2021 and has held it in 14 quarters since. The position peaked at $18.4K in Q3 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

TD Capital Management held 52 shares of Amgen worth $18.4K as of Q1 2026.
TD Capital Management bought 13 Amgen shares in Q1 2026, an estimated $4.63K.
Amgen made up ﹤0.01% of TD Capital Management's portfolio in Q1 2026, its #379 holding.
TD Capital Management first reported a position in Amgen in Q1 2021 and has held it in 14 quarters since.
TD Capital Management's Amgen position peaked at $18.4K in Q3 2025.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.